6Vossebeld PJM,Tissing MH,van Denberg HM. In vivo recovery and safety of human factor ⅧⅧ product AAFACT in patients with haemophilia A[J].{H}HAEMOPHILIA,2003,(2):157-163. 被引量：1
7Tagabiello G,Davolipg,Gajo GB. Safety and effcacy of highpurity concentrates in haemophiliac patients undergoing surgery by continuous infusion[J].{H}HAEMOPHILIA,1999,(6):426-430. 被引量：1
8World Medical Association (WMA). Declaration of Helsinki[OL].http://en.wikipedia.org/wiki/Declaration_of_Helsinki,2004. 被引量：1
